Compare Eli Lilly And Co (LLY) vs Philip Morris International Inc. (PM) Price & Performance

Eli Lilly And CoTrade

Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Philip Morris International Inc. — how do they compare? Eli Lilly And Co trades at $1,215.28 (market cap $1.10T), while Philip Morris International Inc. trades at $185.76 (market cap $289.90B). The key difference: Eli Lilly And Co is far larger — about 3.8× Philip Morris International Inc.'s market cap, and Philip Morris International Inc. pays the higher dividend (3.16%). Which is the better fit depends on your goals.

	LLY	PM
Market Cap	$1.10T	$289.90B
Sector	Health	Consumer Staples
52-Week High	$1.24K	$200.17
52-Week Low	$639.43	$144.33
Enterprise Value	$1.14T	$333.02B
Dividend Yield	0.56%	3.16%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

No Aura AI signal available yet.

Philip Morris International Inc.

Philip Morris International (PM) trades at $186.22, down 1.77% with mixed technical signals. The company reported strong Q1 and Q2 2026 earnings beats but faces margin pressure from rising costs. Revenue grew to $40.65B in 2025 with a robust 25.56% net income margin. Analyst consensus remains bullish with a $211.17 price target, though recent news highlights challenges including a $500M impairment charge and increased illicit cigarette trade in Europe.

PM offers solid fundamentals with high profitability and dividend yield, but near-term headwinds from cost inflation and regulatory risks warrant caution. The stock's valuation at 25.54x P/E is reasonable given earnings growth potential, making it attractive for long-term investors despite current volatility.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Eli Lilly posts strong Q2 with revenue beat and raises full-year guidance, stock up nearly 10% last week.24/7 Wall Street · 22 hours agoBullish Eli Lilly adopts Veeva Vault CRM globally to enhance medicine delivery using AI.PRNewsWire · 1 day agoBullish Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

Invesco's PEY ETF outperforms with a dividend-growth filter, offering higher returns and reliable income.24/7 Wall Street · 16 hours agoBullish View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.